These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 314078)

  • 1. Studies on the use of membrane markers for the differential diagnosis of malignant lymphomas.
    Holowiecki J; Lutz D; Baumgartner G; Hanak H; Knapp W
    Oncology; 1979; 36(3):139-43. PubMed ID: 314078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations bearing different surface markers in non-Hodgkin lymphoma.
    Hołowiecki J; Japa J; Szeruda-Rudzka E; Stella-Hołowiecka B; Krawczyk M; Jarczok K; Rosa B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):845-9. PubMed ID: 749833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas.
    Ben-Bassat H; Goldblum N
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1046-9. PubMed ID: 1055364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHA response of blood and lymph node lymphocytes in vitro in malignant lymphomas.
    Navone R; Stramignoni A
    Acta Haematol; 1974; 51(2):76-83. PubMed ID: 4217079
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin malignant lymphomas of B-cell lineage with special reference to their lymph node involvement pattern.
    Syrjänen KJ
    Arch Geschwulstforsch; 1980; 50(1):66-71. PubMed ID: 6969583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.
    Sun T; Susin M
    Ann Clin Lab Sci; 1987; 17(1):14-26. PubMed ID: 3555278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal Involvement by CD30
    Lezama LS; Gratzinger D
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):245-50. PubMed ID: 2475404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
    Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
    Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization of lymphoproliferative disorders by membrane markers.
    Huber H; Michlmayr G; Huber C; Falkensammer M
    Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration cytopathology of malignant lymphoma.
    Wakely PE
    Clin Lab Med; 1998 Sep; 18(3):541-59, vi-vii. PubMed ID: 9742382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell electrophoretic characterization of lymphoid cells from various sources in patients with malignant non-Hodgkin lymphomas.
    Claus R; Anders O; Nizee H; Behm E; Lakner V; Gunther I; Eggers G; Schulz M; Kusak H
    Allergol Immunopathol (Madr); 1984; 12(5):345-54. PubMed ID: 6524583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.